David P. Calfee, MD

Adjunct Professor of Medicine (Courtesy)

Infectious Diseases (Medicine)

Contact & profiles

Appointments

Adjunct Professor of Medicine (Courtesy)Primary
Medicine · 2024–
Adjunct Professor of Population Health Sciences (Courtesy)
Population Health Sciences · 2026–
Professor of Population Health Sciences
Population Health Sciences · 2020–
Adjunct Professor of Medicine (Courtesy)
NewYork-Presbyterian Hospital

Past Appointments

Professor of Medicine
Medicine · 2017–2024
Professor of Healthcare Policy and Research
Population Health Sciences · 2017–2020
Associate Professor of Healthcare Policy and Research
Population Health Sciences · 2014–2017

Show all 5

Associate Professor of Medicine
Medicine · 2010–2017
Associate Professor of Public Health
Population Health Sciences · 2010–2013

Centers

Clinical & Translational Science Center

Education

M.S.
University of Virginia, 2000
M.D.
West Virginia University School of Medicine, 1995
B.A.
West Virginia University, 1991

Overview

Dr. Calfee’s research interests include the epidemiology and prevention of healthcare-associated infections and antibiotic resistance. Specific research interests include the clinical and molecular epidemiology of multidrug-resistant bacteria (carbapenemase-producing Enterobacteriales and methicillin-resistant S. aureus (MRSA)).

Highlights

1
Infection control and hospital epidemiology · 2023
DPDavid P. Calfee
PMID: 37381690PMCID: PMC10369222DOISenior author127 citations
2
Infection control and hospital epidemiology · 2020
DPDavid P. Calfee
PMID: 32284073DOIFirst author1 citations
3
Infection control and hospital epidemiology · 2024
HMHeidi M. Torres JMJamie Marino MSMatthew S. Simon HKHarjot Kaur Singh+1 more →DPDavid P. Calfee
PMID: 38374787PMCID: PMC11102821DOISenior author3 citations

Publications

147

Funding

Completed grants (9)

Sub-PI
Prevention Epicenters Program: Protecting Patients from Infections, Antibiotic Resistance and Other Adverse Events
Centers for Disease Control and Prevention · 2021–2024 · via University of Maryland
U54CK000615-02
Sub-PI
Risk factors associated with transmission of Candida auris in the acute care setting
Centers for Disease Control and Prevention · 2021–2024 · via University of Maryland
CK000615-03
Sub-PI
Patient and Organism Factors That Increase the Spread of CRE and MRSA
National Institute of Allergy and Infectious Diseases · 2016–2020 · via University of Maryland
R01AI121146-04
PI
Dr. Calfee Biotia Service Agreement
Biotia · 2019–2020Contract
SA 194727-01
Sub-PI
Nursing Intensity of Patient Care Needs and Rates of Healthcare-Associated Infections (NIC-HAI)
Agency for Healthcare Research and Quality · 2016–2019 · via Columbia University
R01HS024915-03
PI
Reducing MDRO & CDI by Improving Environmental Cleaning, Antimicrobial Stewardship, and Education (REALISE)
New York State Department of Health · 2013–2018
C028680
Sub-PI
Optimizing Clinical Use of Polymyxin B: Teaching an Old Drug to Treat Superbugs
National Institute of Allergy and Infectious Diseases · 2016–2017 · via University of Michigan
No publications yet
R01HL119446-03
Sub-PI
Optimizing Clinical Use of Polymyxin B: Teaching an Old Drug to Treat Suberbugs
National Institute of Allergy and Infectious Diseases · 2015–2017 · via Wayne State University
R01AI119446-02
PI
Health Information Technology to Reduce Healthcare-Associated Infections
National Institute of Nursing Research · 2013–2015
R01NR010822-08

Clinical research

Completed & closed trials (1)

PI
Epidemiology of CRE and MRSA Transmission: Patient and Organism Factors
University of Maryland, Baltimore · IRB STUDY CLOSURE (as of 2025)

Overview

Highlights

Publications

Funding

Clinical research

Mentoring

External relationships

Professional Services